PON1 and cancer: Reduced PON1 activity accompanied by increased oxidative stress and inflammation is a common finding in patients with CVD [28,30,57,58], diseases of the kidney [31,32] and liver [59], Alzheimer’s disease [33,60,61], and cancer [34,62] (Table 1).